Skip Navigation

Company News, 2001-03-06, 01:00 AM

Krupp Uhde wins follow-up order from South Korea

Namhae Chemical Corporation, Seoul, has awarded Krupp Uhde a follow-up contract for a nitric acid plant in Yosu, South Korea. This is the third nitric acid plant which is to be built by Krupp Uhde for Namhae Chemical Corporation following the contracts awarded in 1989 and 1996. The scope of supplies includes the licence, the basic engineering, the supply of proprietary equipment and the supervision of the detail engineering, the construction work and the commissioning.

"This new contract is the latest in the long-standing, successful business relationship between our two companies," said the President of Namhae Chemical Corporation, Jong Mou Kim, after the contract had been signed on March, 6. 2001 in Dortmund.

The plant will have a capacity of 1,150 tonnes/day and will be built according to Krupp Uhde`s proprietary dual-pressure process. The plant will also include a waste gas treatment unit based on the latest technology which will reduce the waste gas to such an extent as to enable compliance with the stringent environmental regulations in South Korea to be further reinforced in the future.

The contract is worth approximately euro16 million to Krupp Uhde.

The plant is due to go on stream 24 months after entry into effect of the contract. The entire plant output of 67% azeotropic acid is intended for BASF Korea, with which Namhae Chemical Corp. has concluded a long-term supply contract.

Krupp Uhde has built 14 new plants with a total installed annual capacity of 2.7 million tonnes of nitric acid in the last decade and is thus one of the world`s leading suppliers in this area.

Krupp Uhde is a company in the Technologies segment of the ThyssenKrupp Group and has a workforce of 3,200 employees worldwide. The company`s activities focus on the design and construction of chemical and other industrial plants in the following fields: fertilisers, organic chemicals and plastics, electrolysis, oil & gas and pharmaceuticals.

To the top